Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 33
2007 35
2008 27
2009 34
2010 31
2011 34
2012 41
2013 45
2014 51
2015 53
2016 63
2017 70
2018 62
2019 64
2020 46
2021 55
2022 31
2023 35
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

819 results

Results by year

Filters applied: . Clear all
Page 1
CAR-T Cell Therapy: the Efficacy and Toxicity Balance.
Chohan KL, Siegler EL, Kenderian SS. Chohan KL, et al. Curr Hematol Malig Rep. 2023 Apr;18(2):9-18. doi: 10.1007/s11899-023-00687-7. Epub 2023 Feb 10. Curr Hematol Malig Rep. 2023. PMID: 36763238 Free PMC article. Review.
Supportive Care in Multiple Myeloma.
Guzdar A, Costello C. Guzdar A, et al. Curr Hematol Malig Rep. 2020 Apr;15(2):56-61. doi: 10.1007/s11899-020-00570-9. Curr Hematol Malig Rep. 2020. PMID: 32172361 Review.
MLL-Rearranged Acute Lymphoblastic Leukemia.
El Chaer F, Keng M, Ballen KK. El Chaer F, et al. Curr Hematol Malig Rep. 2020 Apr;15(2):83-89. doi: 10.1007/s11899-020-00582-5. Curr Hematol Malig Rep. 2020. PMID: 32350732 Review.
Chronic Myeloid Leukemia: Beyond BCR-ABL1.
Zhou T, Medeiros LJ, Hu S. Zhou T, et al. Curr Hematol Malig Rep. 2018 Dec;13(6):435-445. doi: 10.1007/s11899-018-0474-6. Curr Hematol Malig Rep. 2018. PMID: 30370478 Review.
Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).
Odetola O, Ma S. Odetola O, et al. Curr Hematol Malig Rep. 2023 Oct;18(5):130-143. doi: 10.1007/s11899-023-00700-z. Epub 2023 Jun 6. Curr Hematol Malig Rep. 2023. PMID: 37278884 Free PMC article. Review.
MRD in ALL: Optimization and Innovations.
Pierce E, Mautner B, Mort J, Blewett A, Morris A, Keng M, El Chaer F. Pierce E, et al. Curr Hematol Malig Rep. 2022 Aug;17(4):69-81. doi: 10.1007/s11899-022-00664-6. Epub 2022 May 26. Curr Hematol Malig Rep. 2022. PMID: 35616771 Review.
Enteropathy-Associated T cell Lymphoma.
Al Somali Z, Hamadani M, Kharfan-Dabaja M, Sureda A, El Fakih R, Aljurf M. Al Somali Z, et al. Curr Hematol Malig Rep. 2021 Apr;16(2):140-147. doi: 10.1007/s11899-021-00634-4. Epub 2021 May 19. Curr Hematol Malig Rep. 2021. PMID: 34009525 Review.
MRD Assessment in Multiple Myeloma: Progress and Challenges.
Bertamini L, D'Agostino M, Gay F. Bertamini L, et al. Curr Hematol Malig Rep. 2021 Apr;16(2):162-171. doi: 10.1007/s11899-021-00633-5. Epub 2021 May 5. Curr Hematol Malig Rep. 2021. PMID: 33950462 Free article. Review.
A Review of Autologous Stem Cell Transplantation in Lymphoma.
Zahid U, Akbar F, Amaraneni A, Husnain M, Chan O, Riaz IB, McBride A, Iftikhar A, Anwer F. Zahid U, et al. Curr Hematol Malig Rep. 2017 Jun;12(3):217-226. doi: 10.1007/s11899-017-0382-1. Curr Hematol Malig Rep. 2017. PMID: 28478586 Free PMC article. Review.
819 results